(Q38977465)

8 September 2017

1 reference

title

Mesenchymal stem cells moderate immune response of type 1 diabetes (English)

1 reference

8 September 2017

0 references

mesenchymal stem cell

1 reference

Junbi Xv

1 reference

8 September 2017

Qianwen Ming

1 reference

8 September 2017

Xiaotong Wang

1 reference

8 September 2017

Wenjing Zhang

1 reference

8 September 2017

Zheng Li

1 reference

8 September 2017

Shuai Wang

1 reference

8 September 2017

Yulin Li

1 reference

8 September 2017

Lisha Li

1 reference

8 September 2017

publication date

10 October 2016

1 reference

8 September 2017

published in

Cell and Tissue Research

1 reference

8 September 2017

volume

368

1 reference

8 September 2017

1 reference

8 September 2017

page(s)

239-248

1 reference

A comparative study of mesenchymal stem cell transplantation with its paracrine effect on control of hyperglycemia in type 1 diabetic rats.

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

HCELL Expression on Murine MSC Licenses Pancreatotropism and Confers Durable Reversal of Autoimmune Diabetes in NOD Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated β-cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Th17 cells: from precursors to players in inflammation and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Mesenchymal stromal cells: sensors and switchers of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Stem cell therapy to cure type 1 diabetes: from hype to hope

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Concise review: mesenchymal stem cells for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Mesenchymal stromal cells: facilitators of successful transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Mesenchymal stem cells help pancreatic islet transplantation to control type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Immunological applications of stem cells in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Update of mortality attributable to diabetes for the IDF Diabetes Atlas: Estimates for the year 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Long-term outcome after pancreas transplantation: a registry analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Mesenchymal stromal cells improve survival during sepsis in the absence of heme oxygenase-1: the importance of neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

The role of immunosuppression of mesenchymal stem cells in tissue repair and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Potential role of mesenchymal stromal cells in pancreatic islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

NFAT pulls the strings during CD4+ T helper cell effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

IL-17 immunity in human type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Effect and mechanisms of human Wharton's jelly-derived mesenchymal stem cells on type 1 diabetes in NOD model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

TSG-6 produced by hMSCs delays the onset of autoimmune diabetes by suppressing Th1 development and enhancing tolerogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Mesenchymal stromal cells and the innate immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Immune modulation of co-transplantation mesenchymal stem cells with islet on T and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Mesenchymal stem cells: a double-edged sword in regulating immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Soluble molecules are key in maintaining the immunomodulatory activity of murine mesenchymal stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

MSCs inhibit bone marrow-derived DC maturation and function through the release of TSG-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Mesenchymal stem cells prevent acute rejection and prolong graft function in pancreatic islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Characterization and functionality of cell surface molecules on human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Bone marrow is a major reservoir and site of recruitment for central memory CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

PI3kα and STAT1 Interplay Regulates Human Mesenchymal Stem Cell Immune Polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Modulation of bone marrow stromal cell functions in infectious diseases by toll-like receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Immunologic and genetic factors in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Are cultured mesenchymal stromal cells an option for immunomodulation in transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Adipose tissue-derived mesenchymal stem cells exert in vitro immunomodulatory and beta cell protective functions in streptozotocin-induced diabetic mice model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

A double mechanism for the mesenchymal stem cells' positive effect on pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Human gingiva-derived mesenchymal stromal cells attenuate contact hypersensitivity via prostaglandin E2-dependent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Enforced hematopoietic cell E- and L-selectin ligand (HCELL) expression primes transendothelial migration of human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Sarcoma derived from cultured mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Immunoregulatory function of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

How diverse--CD4 effector T cells and their functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Immunological characteristics of human umbilical cord mesenchymal stem cells and the therapeutic effects of their transplantion on hyperglycemia in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon microenvironmental manipulation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Multipotent human mesenchymal stromal cells mediate expansion of myeloid-derived suppressor cells via hepatocyte growth factor/c-met and STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Human mesenchymal stem cells modulate cellular immune response to islet antigen glutamic acid decarboxylase in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Natural regulatory T cells control the development of atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Human mesenchymal stem cell-derived microvesicles modulate T cell response to islet antigen glutamic acid decarboxylase in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-016-2499-2

Spontaneous human adult stem cell transformation.

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1158/0008-5472.CAN-04-4194

Identifiers

DOI

10.1007/S00441-016-2499-2

1 reference

Dimensions Publication ID

8 September 2017

1020017850

0 references

1 reference